AWM
CRMD icon

Affinity Wealth Management’s CorMedix CRMD Stock Holding History

Affinity Wealth Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-16,070
Closed -$152K – 99
2019
Q1 		$152K Hold
16,070
– – 0.06% 99
2018
Q4 		$104K Buy
+16,070
New +$107K 0.06% 93

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SC
Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return

Affinity Wealth Management's CRMD Position: Q2 2019 in Review

Affinity Wealth Management sold out of CorMedix (CRMD) in Q2 2019, closing a stake of 16,070 shares — an estimated $152K sold.

Affinity Wealth Management first reported a position in CRMD in Q4 2018 and held it in 2 quarters. The position peaked at $152K in Q1 2019. 47 funds tracked by Wall St. Rank hold CRMD as of Q2 2019.

  • Affinity Wealth Management reported no remaining CorMedix position as of Q2 2019 after selling out during the quarter.
  • Affinity Wealth Management sold 16,070 CorMedix shares in Q2 2019, an estimated $152K.
  • Affinity Wealth Management first reported a position in CorMedix in Q4 2018 and held it in 2 quarters.
  • Affinity Wealth Management's CorMedix position peaked at $152K in Q1 2019.
  • 47 funds tracked by Wall St. Rank held CorMedix as of Q2 2019.

Based on Affinity Wealth Management's 13F filing for Q2 2019, filed 24 Jul 2019.